$100 Invested In This Inventory 15 Years In the past Would Be Price This A lot At the moment – Regeneron Prescription drugs (NASDAQ:REGN)

Regeneron Prescription drugs REGN has outperformed the market over the previous 15 years by 12.66% on an annualized foundation producing a median annual return of 24.59%. Presently, Regeneron Prescription drugs has a market capitalization of $77.22 billion.

Shopping for $100 In REGN: If an investor had purchased $100 of REGN inventory 15 years in the past, it might be price $2,688.18 at present primarily based on a value of $702.69 for REGN on the time of writing.

Regeneron Prescription drugs’s Efficiency Over Final 15 Years

Lastly — what is the level of all this? The important thing perception to take from this text is to notice how a lot of a distinction compounded returns could make in your money development over a time period.

This text was generated by Benzinga’s automated content material engine and reviewed by an editor.